MN-25 is a synthetic cannabinoid (CB) with greater affinity for the peripheral CB₂ receptor (K_i = 11 nM) than for the central CB₁ receptor (K_i = 245 nM).¹ However, this compound does not block LPS-induced TNF-α production in mice, an inhibitory effect produced by other CB₂ agonists.^2,1,3 This product is intended for forensic and research purposes.

≥95%